|
News For VVUS;JNJ;AZN;PFE From The Last 14 Days Check below for free stories on VVUS;JNJ;AZN;PFE the last two weeks. |
|
|
| May 9, 2013 |
| 09:51 EDT |  | JNJ | J&J unit says first patient enrolled in reMARQable study
 Subscribe for More Information |
|
| May 8, 2013 |
| 10:33 EDT | | PFE | Bristol-Myers, Pfizer announced results from ARISTOTLE trial subanalysis
Bristol-Myers (BMY) and Pfizer (PFE) announced yesterday that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from the subanalysis showed that the reductions in stroke or systemic embolism, number of major bleeding events and mortality demonstrated with Eliquis compared to warfarin in the ARISTOTLE trial were consistent across subgroups defined based on levels of International Normalized Ratio control in patients with nonvalvular atrial fibrillation. This story corrects a headline from yesterday. |
|
| 07:38 EDT |  | JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| 07:35 EDT |  | VVUS | VIVUS reports Q1 EPS (53c), consensus (51c)
Reports Q1 revenue $4.11M, consensus $5.22M. |
|
| May 7, 2013 |
| 16:52 EDT | | VVUS | First Manhattan Co. releases case for full board change at VIVUS
Subscribe for More Information |
|
| 12:32 EDT |  | PFE | High option volume stocks: ALDW BC NMM PFE AEP
|
|
| 08:09 EDT | | PFE | Accelrys, Pfizer extend agremeent for global deployment of Lifecycle software
Subscribe for More Information |
|
| May 6, 2013 |
| 17:03 EDT | | PFE | Bristol-Myers, Pfizer announce publication of ARISTOTLE trial
Bristol-Myers Squibb (BMY) and Pfizer (PFE) announced that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from this subanalysis showed that the reductions in stroke or systemic embolism, number of major bleeding events and mortality demonstrated with Eliquis compared to warfarin in the ARISTOTLE trial were consistent across subgroups defined based on levels of International Normalized Ratio control in patients with nonvalvular atrial fibrillation. Based on the results of the subanalysis, the benefits of Eliquis compared with warfarin for stroke or systemic embolism, bleeding, and mortality appear similar across the range of centers' and patients' quality of INR control. |
|
| 16:23 EDT | | AZN | Array to start first company-led Phase 3 trial with MEK162
Array (ARRY) announced the planned start of its first company-led Phase 3 trial with MEK162 in low-grade serous ovarian cancer. This is the third MEK162 pivotal trial that is expected to initiate in 2013 and one of five pivotal trials Array expects to begin in 2013 on Array-invented products. Novartis (NVS), who is co-developing MEK162 with Array, previously stated that Phase 3 trials in NRAS-mutant melanoma and BRAF-mutant melanoma are expected to start this year and AstraZeneca has announced its plans to initiate two registration trials with selumetinib, a MEK inhibitor invente (AZN) d by Array, in KRAS-mutant non-small cell lung cancer and in thyroid cancer. Array also recently released initial data on its wholly-owned hematology drug, ARRY-520, from a combination trial with Velcade® (bortezomib) in patients with relapsed or refractory multiple myeloma (MM), showing that the drug was generally well-tolerated and showed initial signs of activity in this heavily pretreated population. |
|
| 13:16 EDT | | AZN | AstraZeneca management to meet with Jefferies
Meeting to be held in New York on May 9 hosted by Jefferies. |
| |
| 11:29 EDT |  | JNJ | J&J cosmetics license revoked at Mumbai plant, Reuters says
Subscribe for More Information |
|
| 08:02 EDT | | PFE | Pfizer launches Viagra home delivery, powered by CVS/pharmacy
To meet the needs of consumers who are increasingly going online to purchase prescription medications, Pfizer (PFE) launched Viagra home delivery, a new prescription-fulfillment website for Viagra tablets, Pfizer’s most counterfeited medicine. The site, which is powered by CVS/pharmacy (CVS) and accessible through Viagra.com, offers men with erectile dysfunction an opportunity to purchase Viagra online with a valid prescription from a trusted source. |
|
| 07:51 EDT | | PFE | Pfizer to sell Viagra directly to patients on its website, Fox News reports
In a move that changes the drug industry's distribution model, Pfizer told The Associated Press that it will begin selling Viagra directly to patients on its website, reports Fox News. Men still will need a prescription to buy it, and Pfizer is offering three free pills with the first order and 30% off the second one. Reference Link |
|
| 07:34 EDT | | PFE | Conference Forum to host a summit
Subscribe for More Information |
|
| 07:27 EDT | | AZN | Bristol-Myers, AstraZeneca announces results of metreleptin study
Subscribe for More Information |
|
| 07:24 EDT | | JNJ, PFE | Drug companies attempt to make painkillers that can't be abused, WSJ reports
Subscribe for More Information |
|
| 07:18 EDT | | PFE | American Congress of Obstetrics and Gynecology to hold annual meeting
Subscribe for More Information |
|
|
|
|
|
